BioCryst Pharma (BCRX) PT Raised to $18 at Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on BioCryst Pharma (NASDAQ: BCRX) to $18.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
